Rahul Ballal is a biotech executive with over 15 years of experience in company building, financing, and business development. As CEO of Mediar Therapeutics, he focuses on pioneering novel fibrosis treatments. He previously led Imara from Series A through an IPO and subsequent merger, demonstrating significant expertise in corporate growth.
Deeply committed to patient welfare, Rahul actively supports initiatives for families suffering from rare conditions like hemoglobin disorders. He emphasizes teamwork and innovative partnerships to advance science for those in need. He serves on the Annual Fund Committee and as Secretary for The Park School in Brookline, MA.
An interesting fact: Rahul started his career in Silicon Valley as the founder and CEO of a venture-backed data analytics start-up, which he later sold.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.